Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy (original) (raw)

• Harper, M.E., Marselle, L.M., Gallo, R.C., & Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83,772–776 (1986).
  Article CAS Google Scholar
• Coombs, R.W. et al. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 321, 626–1631 (1989).
  Article Google Scholar
• Ho, D.D., Moudgil, T. & Alam, M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321, 1621–1625 (1989).
  Article CAS Google Scholar
• Psallidopoulus, M.C. et al. Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J. Virol. 63, 4626–4631 (1989).
  Google Scholar
• Schnittman, S.M. et al. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245, 305–308 (1989).
  Article CAS Google Scholar
• Daar, E.S., Moudgil, T., Meyer, R.D. & Ho, D.D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324, 961–964 (1991).
  Article CAS Google Scholar
• Pantaleo, G. et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88, 9838–9842 (1991).
  Article CAS Google Scholar
• Pantaleo, G. et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355–358 (1993).
  Article CAS Google Scholar
• Piatak, M. Jr. et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749–1754 (1993).
  Article CAS Google Scholar
• Mellors, J.W., Rinaldo, Jr., C.W., Gupta, P., White, R.M., Todd, J.A. & Kingsley, L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167–1170 (1996).
  Article CAS Google Scholar
• Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117–122 (1995).
  Article CAS Google Scholar
• Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. & Markowitz, M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123–126 (1995).
  Article CAS Google Scholar
• Perelson, A.S, Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. HIV-1 dynamics in vivo, virion clearance rate, infected cell life-span, viral generation time. Science 271, 1582–1586 (1996).
  Article CAS Google Scholar
• Perelson, A.S. et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188–191 (1997).
  Article CAS Google Scholar
• Gulick, R.M. et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734–739 (1997).
  Article CAS Google Scholar
• Hammer, S.M. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med. 337, 725–733 (1997).
  Article CAS Google Scholar
• Harris, M. et al. Correlation of virus load in plasma and lymph node tissue in human immunodeficiency virus infection. J. Infect. Dis. 176, 1388–1392 (1997).
  Article CAS Google Scholar
• Nabel, G. & Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711–713 (1987).
  Article CAS Google Scholar
• Folks, T.M. et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86, 2365–2368 (1989).
  Article CAS Google Scholar
• Pomerantz, R.J., Trono, D., Feinberg, M.B., & Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression, a molecular model for latency. Cell 61, 1271–1276 (1990).
  Article CAS Google Scholar
• Garcia-Blanco, M.A. & Cullen, B.R. Molecular basis of latency in pathogenic human viruses. Science 254, 815–820 (1991).
  Article CAS Google Scholar
• Chun, T.-W. et al. Fate of HIV-1-infected T cells in vivo, Rates of transition to stable latency. Nature Med. 1, 1284–1290 (1995).
  Article CAS Google Scholar
• Chun, T.-W. et al. Quantitation of latent tissue reservoirs and total body load in HIV-1 infection. Nature 387, 183–188 (1997).
  Article CAS Google Scholar
• Folks, T. et al. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J. Immunol. 136, 4049–4053 (1986).
  CAS PubMed Google Scholar
• Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295–1300 (1997).
  Article CAS Google Scholar
• Chun, T.W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94, 13193–13197 (1997).
  Article CAS Google Scholar
• Wong, J.K. et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc. Natl. Acad. Sci. USA 94, 12574–12579 (1997).
  Article CAS Google Scholar
• Carpenter, C.C. et al. Antiretroviral therapy for HIV infection in 1998, undated recommendation of the International AIDS Society - USA Panel. J. Am. Med. Assoc. 280, 78–86 (1998).
  Article CAS Google Scholar
• Bartlett, J.G. in Medical Management of HIV Infection (Johns Hopkins University, Baltimore, Maryland, 1998).
  Google Scholar
• Laird, N.M. & Ware, J.H. Random effects models for longitudinal data. Biometrics 38, 963–974 (1982).
  Article CAS Google Scholar
• Palella, F.J. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338, 853–860 (1998).
  Article Google Scholar
• Flexner, C. HIV-1 protease inhibitors. N. Engl. J. Med. 338, 1281–1292 (1998).
  Article CAS Google Scholar
• Mclean, A.R. & Michie, C.A. In vivo estimates of division and death rates of human T lymphocytes. X. Proc. Natl. Acad. Sci. USA 92, 3707–3711 (1995).
  Article CAS Google Scholar
• Natarajan, V. et al. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet 353, 119–120 (1999).
  Article CAS Google Scholar
• Gunthard, H.F. et al. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72, 2422–2428 (1998).
  CAS PubMed Google Scholar
• Rosenberg, E.S. et al. Vigorous HIV-1-specific CD4+ T cell responses associated with the control of viremia. Science 278, 1447–1450 (1997).
  Article CAS Google Scholar
• Jacobson, E.L., Pilaro, F., & Smith, K.A. Rational interleukin 2 therapy for HIV positive individuals, Daily low doses enhace immune fuction without toxicity. Proc. Natl. Acad. Sci. USA 93, 10405–10410 (1996).
  Article CAS Google Scholar
• Chun, T.-W. et al. Effect of interleukin-2 in diminution of a pool of latently infected, resting CD4+ T cells in HIV-1 infected patients receiving highly active antiretroviral therapy (6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, 1999).
• Myers, L.A., McQuay, L.J. & Hollinger, F.B. Dilution assay statistics. J. Clin. Micro. 32, 732–739 (1994).
  CAS Google Scholar
• Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes, molecular analysis reveals a labile, latent viral structure. Cell 61, 213–222 (1990).
  Article CAS Google Scholar
• Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P. & Stevenson, M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423–427 (1991).
  Article CAS Google Scholar